Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.
about
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immune activation and HIV-spec ...... An exploratory clinical trial.
@ast
Immune activation and HIV-spec ...... An exploratory clinical trial.
@en
type
label
Immune activation and HIV-spec ...... An exploratory clinical trial.
@ast
Immune activation and HIV-spec ...... An exploratory clinical trial.
@en
prefLabel
Immune activation and HIV-spec ...... An exploratory clinical trial.
@ast
Immune activation and HIV-spec ...... An exploratory clinical trial.
@en
P2093
P2860
P50
P1433
P1476
Immune activation and HIV-spec ...... An exploratory clinical trial.
@en
P2093
Anders Dahm
Anne Ma Dyrhol-Riise
Christian Prebensen
Ingeborg Aaberge
Kristian Waalen
Marius Trøseid
P2860
P304
P356
10.1371/JOURNAL.PONE.0176527
P407
P577
2017-05-02T00:00:00Z